← Evidence map

ReviewDrug design, development and therapy2017

Spotlight on ertugliflozin and its potential in the treatment of type 2 diabetes: evidence to date.

Francesca Cinti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

40 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 29042751